EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, WuXi XDC Cayman's Enterprise Value is €3,850.4 Mil.
WuXi XDC Cayman's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was €-109.5 Mil. Therefore, WuXi XDC Cayman's EV-to-FCF for today is -35.16.
The historical rank and industry rank for WuXi XDC Cayman's EV-to-FCF or its related term are showing as below:
STU:L74'
s EV-to-FCF Range Over the Past 10 Years
Min: -137.9 Med: -71.04 Max: 685.81
Current: -33.5
During the past 4 years, the highest EV-to-FCF of WuXi XDC Cayman was 685.81. The lowest was -137.90. And the median was -71.04.
STU:L74's EV-to-FCF is ranked worse than 100% of 98
companies
in the Medical Diagnostics & Research industry
Industry Median: 24.8
vs STU:L74: -33.50
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
The historical data trend for WuXi XDC Cayman's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of WuXi XDC Cayman's EV-to-FCF
For the Diagnostics & Research subindustry, WuXi XDC Cayman's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WuXi XDC Cayman's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, WuXi XDC Cayman's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where WuXi XDC Cayman's EV-to-FCF falls into.
WuXi XDC Cayman's current Enterprise Value is €3,850.4 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. WuXi XDC Cayman's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was €-109.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WuXi XDC Cayman (STU:L74) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
WuXi XDC Cayman's PE Ratio (TTM) for today is calculated as:
WuXi XDC Cayman's share price for today is €3.52.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. WuXi XDC Cayman's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €0.063.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
WuXi XDC Cayman EV-to-FCF Related Terms
Thank you for viewing the detailed overview of WuXi XDC Cayman's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
WuXi XDC Cayman Inc is a leading CRDMO focused on the global ADC and broader bioconjugate market and the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, It offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development and manufacturing. The company provides these services from proximately located, state-of-the-art laboratories and manufacturing facilities, leading to the significant reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development and manufacturing platform, its mission is to continuously enhance its platform, and propel and transform the development of the bioconjugate industry.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:L74 has been successfully added to your